Seventeen of 62 patients had skin or nipple infiltrations (27.4%) according to the
pathological reports. A total of 33 patients underwent testing of hormone receptors. The …

We conducted an analysis on 41 cases of male breast cancer (median age 54 y; range 25–
82 y) in Kuwait. Most (51%) were stage II cancers with 65% arising in the left breast. There …

Twenty‐nine male breast cancers (MBC) were studied to determine the relationship
between expression of several prognostic factors and clinical outcome …

Backgrounds Male breast cancer (MBC) is a rare disease and accounts for< 1% of all breast
cancers. Methods We retrospectively analyzed clinicopathologic characteristics and …

Purpose Breast cancer in male is uncommon, accounting for approximately 1% of all breast
cancer and less than 1.5% of all the malignant neoplasms in males. The information …

Background Male breast cancer has traditionally been compared with female breast cancer,
using the same staging system and prognostic indicators. A variety of histochemical and …

Purpose: To retrospectively evaluate the 15-year experience with breast cancer in males at
a single institution. Methods: The data from 25 male patients who had undergone surgery for …

Prognostic factors in male breast cancer (MaBC) are controversial. The objective of this
study was to analyze patient characteristics and prognostic factors in MaBC over the last …

Objectives The optimal treatment for male breast cancer is not known because male breast
cancer is a rare disease. It represents as little as 0.6% of all breast cancers and less than 1 …

Male breast cancer is a rare disease. The aim of this study was to compare overall survival
(OS) and disease‑free survival (DFS) in a group of matched males and females with breast …